{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T18:26:42Z","timestamp":1787596002318,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871002"],"award-info":[{"award-number":["81871002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing, Chongqing, China","doi-asserted-by":"publisher","award":["cstc2017jcjAX0211"],"award-info":[{"award-number":["cstc2017jcjAX0211"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Joint Project of Zunyi Science and Technology Department of Social Development, Guizhou, China","award":["[2018] 31"],"award-info":[{"award-number":["[2018] 31"]}]},{"name":"Science and Technology Program of Yuzhong District, Chongqing, China","award":["20150134"],"award-info":[{"award-number":["20150134"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.cbi.2019.05.004","type":"journal-article","created":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T09:01:16Z","timestamp":1557133276000},"page":"116-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Activation of 20-HETE\/PPARs involved in reno-therapeutic effect of naringenin on diabetic nephropathy"],"prefix":"10.1016","volume":"307","author":[{"given":"Shumei","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongchun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunliang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oumei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingsong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2019.05.004_bib1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","article-title":"IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045","volume":"138","author":"Cho","year":"2018","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.cbi.2019.05.004_bib2","first-page":"1875870","article-title":"Oxidative stress, apoptosis, and mitochondrial function in diabetic nephropathy","volume":"2018","author":"Sifuentes-Franco","year":"2018","journal-title":"Internet J. Endocrinol."},{"key":"10.1016\/j.cbi.2019.05.004_bib3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/ki.2014.128","article-title":"Diabetic kidney disease: a clinical update from kidney disease: improving global outcomes","volume":"87","author":"Molitch","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.cbi.2019.05.004_bib4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejphar.2017.03.042","article-title":"Metformin-like antidiabetic, cardio-protective and non-glycemic effects of naringenin: molecular and pharmacological insights","volume":"803","author":"Nyane","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2019.05.004_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/nu9101161","article-title":"Flavonoid naringenin attenuates oxidative stress, apoptosis and improves neurotrophic effects in the diabetic rat retina","volume":"9","author":"Al-Dosari","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.cbi.2019.05.004_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejphar.2016.01.002","article-title":"Apigenin and naringenin regulate glucose and lipid metabolism, and ameliorate vascular dysfunction in type 2 diabetic rats","volume":"773","author":"Ren","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2019.05.004_bib7","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1179\/1743132815Y.0000000079","article-title":"Naringenin neutralises oxidative stress and nerve growth factor discrepancy in experimental diabetic neuropathy","volume":"37","author":"Al-Rejaie","year":"2015","journal-title":"Neurol. Res."},{"key":"10.1016\/j.cbi.2019.05.004_bib8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbrc.2018.05.119","article-title":"Naringenin exhibits the protective effect on cardiac hypertrophy via EETs-PPARs activation in streptozocin-induced diabetic mice","volume":"502","author":"Zhang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2019.05.004_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/pharmaceutics9010009","article-title":"Clinical implications of 20-hydroxyeicosatetraenoic acid in the kidney, liver, lung and brain: an emerging therapeutic target","volume":"9","author":"Elshenawy","year":"2017","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.cbi.2019.05.004_bib10","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.prostaglandins.2016.05.007","article-title":"The role of 20-HETE in cardiovascular diseases and its risk factors","volume":"125","author":"Waldman","year":"2016","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.cbi.2019.05.004_bib11","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1124\/dmd.106.013839","article-title":"Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha","volume":"35","author":"Ng","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2019.05.004_bib12","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00011-016-0922-5","article-title":"Contribution of PPARalpha\/beta\/gamma, AP-1, importin-alpha3, and RXRalpha to the protective effect of 5,14-HEDGE, a 20-HETE mimetic, against hypotension, tachycardia, and inflammation in a rat model of septic shock","volume":"65","author":"Senol","year":"2016","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.cbi.2019.05.004_bib13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00394-010-0117-8","article-title":"Dietary naringenin increases hepatic peroxisome proliferators-activated receptor alpha protein expression and decreases plasma triglyceride and adiposity in rats","volume":"50","author":"Cho","year":"2011","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.cbi.2019.05.004_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012399","article-title":"Transcriptional regulation of human and rat hepatic lipid metabolism by the grapefruit flavonoid naringenin: role of PPARalpha, PPARgamma and LXRalpha","volume":"5","author":"Goldwasser","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2019.05.004_bib15","doi-asserted-by":"crossref","first-page":"7093","DOI":"10.3892\/mmr.2015.4232","article-title":"Naringin ameliorates cognitive deficits via oxidative stress, proinflammatory factors and the PPARgamma signaling pathway in a type 2 diabetic rat model","volume":"12","author":"Qi","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.cbi.2019.05.004_bib16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/01635581.2015.976320","article-title":"Chemopreventive and therapeutic potential of \"naringenin,\" a flavanone present in citrus fruits","volume":"67","author":"Mir","year":"2015","journal-title":"Nutr. Canc."},{"key":"10.1016\/j.cbi.2019.05.004_bib17","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.intimp.2018.07.027","article-title":"Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-kappaB\/p38 signaling pathway in high-fat diet\/streptozotocin-induced diabetic mice","volume":"63","author":"Song","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cbi.2019.05.004_bib18","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrneph.2017.142","article-title":"Modelling diabetic nephropathy in mice","volume":"14","author":"Azushima","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.cbi.2019.05.004_bib19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.diabres.2017.04.019","article-title":"Involvement of glucose-regulated protein 78 and spliced X-box binding protein 1 in the protective effect of gliclazide in diabetic nephropathy","volume":"146","author":"Zhang","year":"2017","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.cbi.2019.05.004_bib20","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1097\/01.ASN.0000089829.45296.7C","article-title":"Evaluation of a thick and thin section method for estimation of podocyte number, glomerular volume, and glomerular volume per podocyte in rat kidney with Wilms' tumor-1 protein used as a podocyte nuclear marker","volume":"14","author":"Sanden","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cbi.2019.05.004_bib21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3389\/fphar.2019.00027","article-title":"Ferulic acid protects hyperglycemia-induced kidney damage by regulating oxidative insult, inflammation and autophagy","volume":"10","author":"Chowdhury","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cbi.2019.05.004_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1478-7954-8-29","article-title":"Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence","volume":"8","author":"Boyle","year":"2010","journal-title":"Popul. Health Metrics"},{"key":"10.1016\/j.cbi.2019.05.004_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/biom9030099","article-title":"Antidiabetic properties of naringenin: a citrus fruit polyphenol","volume":"9","author":"Den Hartogh","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.cbi.2019.05.004_bib24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/iep.12296","article-title":"Establishment of a diabetic myocardial hypertrophy model in Mus musculus castaneus mouse","volume":"99","author":"Zhang","year":"2018","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.cbi.2019.05.004_bib25","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1463-1326.2008.00869.x","article-title":"Antidiabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra-pancreatic glucose regulation","volume":"10","author":"Ortiz-Andrade","year":"2008","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.cbi.2019.05.004_bib26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1515\/aiht-2016-67-2708","article-title":"Naringenin ameliorates pathological changes in liver and kidney of diabetic mice: a preliminary study","volume":"67","author":"Sirovina","year":"2016","journal-title":"Arh. Hig. Rada. Toksikol."},{"key":"10.1016\/j.cbi.2019.05.004_bib27","doi-asserted-by":"crossref","first-page":"8738760","DOI":"10.1155\/2016\/8738760","article-title":"Naringenin ameliorated kidney injury through let-7a\/TGFBR1 signaling in diabetic nephropathy","volume":"2016","author":"Yan","year":"2016","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.cbi.2019.05.004_bib28","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.3109\/13880209.2015.1110599","article-title":"Naringenin ameliorates streptozotocin-induced diabetic rat renal impairment by downregulation of TGF-beta1 and IL-1 via modulation of oxidative stress correlates with decreased apoptotic events","volume":"54","author":"Roy","year":"2016","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.cbi.2019.05.004_bib29","first-page":"693","article-title":"Involvement of renal cytochromes P450 and arachidonic acid metabolites in diabetic nephropathy","volume":"27","author":"Eid","year":"2013","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.cbi.2019.05.004_bib30","doi-asserted-by":"crossref","first-page":"e70029","DOI":"10.1371\/journal.pone.0070029","article-title":"20-HETE and EETs in diabetic nephropathy: a novel mechanistic pathway","volume":"8","author":"Eid","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2019.05.004_bib31","doi-asserted-by":"crossref","first-page":"F556","DOI":"10.1152\/ajprenal.90613.2008","article-title":"Glomerular 20-HETE, EETs, and TGF-beta1 in diabetic nephropathy","volume":"296","author":"Luo","year":"2009","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"10.1016\/j.cbi.2019.05.004_bib32","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/01.HYP.0000085650.29823.F2","article-title":"Role of COX-2 in the enhanced vasoconstrictor effect of arachidonic acid in the diabetic rat kidney","volume":"42","author":"Quilley","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.cbi.2019.05.004_bib33","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1471-4892(03)00015-8","article-title":"HETEs\/EETs in renal glomerular and epithelial cell functions","volume":"3","author":"Natarajan","year":"2003","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.cbi.2019.05.004_bib34","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1523-1755.2005.00065.x","article-title":"Protective effect of 20-hydroxyeicosatetraenoic acid (20-HETE) on glomerular protein permeability barrier","volume":"67","author":"McCarthy","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.cbi.2019.05.004_bib35","doi-asserted-by":"crossref","first-page":"F501","DOI":"10.1152\/ajprenal.00131.2007","article-title":"Role of endogenous CYP450 metabolites of arachidonic acid in maintaining the glomerular protein permeability barrier","volume":"293","author":"Williams","year":"2007","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"10.1016\/j.cbi.2019.05.004_bib36","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00011-006-6190-z","article-title":"Improvement of inflammatory responses associated with NF-kappa B pathway in kidneys from diabetic rats","volume":"57","author":"Chen","year":"2008","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.cbi.2019.05.004_bib37","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.vph.2006.01.004","article-title":"Renoprotective effects of fenofibrate in diabetic rats are achieved by suppressing kidney plasminogen activator inhibitor-1","volume":"44","author":"Chen","year":"2006","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.cbi.2019.05.004_bib38","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1093\/ndt\/gfs358","article-title":"Peroxisome proliferator-activated receptor-delta activation ameliorates albuminuria by preventing nephrin loss and restoring podocyte integrity in type 2 diabetes","volume":"27","author":"Lee","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cbi.2019.05.004_bib39","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.bbrc.2010.06.093","article-title":"Nifedipine inhibits advanced glycation end products (AGEs) and their receptor (RAGE) interaction-mediated proximal tubular cell injury via peroxisome proliferator-activated receptor-gamma activation","volume":"398","author":"Matsui","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2019.05.004_bib40","doi-asserted-by":"crossref","first-page":"F1072","DOI":"10.1152\/ajprenal.00020.2007","article-title":"Antioxidants attenuate high glucose-induced hypertrophic growth in renal tubular epithelial cells","volume":"293","author":"Huang","year":"2007","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"10.1016\/j.cbi.2019.05.004_bib41","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1194\/jlr.M700002-JLR200","article-title":"P450 CYP2C epoxygenase and CYP4A omega-hydroxylase mediate ciprofibrate-induced PPARalpha-dependent peroxisomal proliferation","volume":"48","author":"Gatica","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cbi.2019.05.004_bib42","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1476-5381.2011.01263.x","article-title":"20-Hydroxyeicosatetraenoic acid inhibits ATP-induced COX-2 expression via peroxisome proliferator activator receptor-\u03b1 in vascular smooth muscle cells","volume":"163","author":"Liang","year":"2011","journal-title":"Br. J. Pharmacol."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279718317940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279718317940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:53:38Z","timestamp":1757858018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279718317940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":42,"alternative-id":["S0009279718317940"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2019.05.004","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activation of 20-HETE\/PPARs involved in reno-therapeutic effect of naringenin on diabetic nephropathy","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2019.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}